{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:21:07Z","timestamp":1764645667565,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Skeletal muscle sodium channel disorders give rise to episodic symptoms such as myotonia and\/or periodic paralysis. Chronic symptoms with permanent weakness are not considered characteristic of the phenotypes. Muscle fat replacement represents irreversible damage that inevitably will impact on muscle strength. This study investigates muscle fat replacement and contractility in patients with pathogenic <jats:italic>SCN4A<\/jats:italic> variants compared to healthy controls. T1-weighted and 2-point Dixon MRI of the legs were conducted to assess fat replacement. Stationary dynamometry was used to assess muscle strength. Contractility was determined by maximal muscle contraction divided by cross-sectional muscle area. The average cross-sectional intramuscular fat fraction was greater in patients compared with controls by 2.5% in the calves (95% CI 0.74\u20134.29%, p\u2009=\u20090.007) and by 2.0% in the thighs (95% CI 0.75\u20133.2%, p\u2009=\u20090.003). Muscle contractility was less in patients vs. controls by 14\u201327% (p\u2009&lt;\u20090.05). Despite greater fat fraction and less contractility, absolute strength was not significantly less. This study quantitatively documents greater fat fraction and additionally describes difference in muscle contractility in a large cohort of patients with skeletal muscle sodium channel disorders. The clinical impact of these abnormal findings is likely limited as muscle hypertrophy in the patients served to preserve absolute muscle strength. Subgroup analysis indicated significant difference in phenotype by genotype, however these findings lack statistical significance and serve as inspiration for future researchers to probe into the geno- phenotype relationship in these disorders.<\/jats:p><jats:p><jats:bold>Trial registration:<\/jats:bold> The study was registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">http:\/\/clinicaltrials.gov<\/jats:ext-link> (identifier: NCT04808388).<\/jats:p>","DOI":"10.1038\/s41598-023-29759-7","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T14:06:22Z","timestamp":1676297182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders"],"prefix":"10.1038","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct04808388","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9496-7655","authenticated-orcid":false,"given":"Jonas Jalili","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads Godtfeldt","family":"Stemmerik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura N\u00f8rager","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie Vinther","family":"Skriver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav Rhode","family":"Wilms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Duno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"issue":"16","key":"29759_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","volume":"80","author":"A Horga","year":"2013","unstructured":"Horga, A. et al. Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology 80(16), 1472\u20131475. https:\/\/doi.org\/10.1212\/WNL.0b013e31828cf8d0 (2013).","journal-title":"Neurology"},{"issue":"3","key":"29759_CR2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1046\/j.1523-1755.2000.00914.x","volume":"57","author":"SC Cannon","year":"2000","unstructured":"Cannon, S. C. Spectrum of sodium channel disturbances in the nondystrophic myotonias and periodic paralyses. Kidney Int. 57(3), 772\u2013779. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00914.x (2000).","journal-title":"Kidney Int."},{"issue":"Pt 1","key":"29759_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/brain\/awp294","volume":"133","author":"E Matthews","year":"2010","unstructured":"Matthews, E. et al. The non-dystrophic myotonias: Molecular pathogenesis, diagnosis and treatment. Brain J. Neurol. 133(Pt 1), 9\u201322. https:\/\/doi.org\/10.1093\/brain\/awp294 (2010).","journal-title":"Brain J. Neurol."},{"issue":"4","key":"29759_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ana.25804","volume":"88","author":"JR Dahlqvist","year":"2020","unstructured":"Dahlqvist, J. R., Widholm, P., Leinhard, O. D. & Vissing, J. MRI in neuromuscular diseases: An emerging diagnostic tool and biomarker for prognosis and efficacy. Ann. Neurol. 88(4), 669\u2013681. https:\/\/doi.org\/10.1002\/ana.25804 (2020).","journal-title":"Ann. Neurol."},{"issue":"1","key":"29759_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pmr.2011.11.004","volume":"23","author":"EL Finanger","year":"2012","unstructured":"Finanger, E. L. et al. Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne Muscular Dystrophy. Phys. Med. Rehabil. Clin. N. Am. 23(1), 1\u2013ix. https:\/\/doi.org\/10.1016\/j.pmr.2011.11.004 (2012).","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"issue":"5","key":"29759_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/WCO.0000000000000851","volume":"33","author":"C Nu\u00f1ez-Peralta","year":"2020","unstructured":"Nu\u00f1ez-Peralta, C., Alonso-P\u00e9rez, J. & D\u00edaz-Manera, J. The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases. Curr. Opin. Neurol. 33(5), 611\u2013620. https:\/\/doi.org\/10.1097\/WCO.0000000000000851 (2020).","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"29759_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jmri.20804","volume":"25","author":"E Mercuri","year":"2007","unstructured":"Mercuri, E. et al. Muscle MRI in inherited neuromuscular disorders: Past, present, and future. J. Magn. Reason. Imaging. 25(2), 433\u2013440. https:\/\/doi.org\/10.1002\/jmri.20804 (2007).","journal-title":"J. Magn. Reason. Imaging."},{"issue":"2\u20133","key":"29759_CR8","first-page":"95","volume":"34","author":"J D\u00edaz-Manera","year":"2015","unstructured":"D\u00edaz-Manera, J., Llauger, J., Gallardo, E. & Illa, I. Muscle MRI in muscular dystrophies. Acta Myol. Myopathies Cardiomyopathies Off. J. Mediterr. Soc. Myol. 34(2\u20133), 95\u2013108 (2015).","journal-title":"Acta Myol. Myopathies Cardiomyopathies Off. J. Mediterr. Soc. Myol."},{"issue":"3","key":"29759_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/jmri.21492","volume":"28","author":"J Ma","year":"2008","unstructured":"Ma, J. Dixon techniques for water and fat imaging. J. Magn. Reason. Imaging. 28(3), 543\u2013558. https:\/\/doi.org\/10.1002\/jmri.21492 (2008).","journal-title":"J. Magn. Reason. Imaging."},{"key":"29759_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mito.2018.07.001","volume":"46","author":"NS Poulsen","year":"2019","unstructured":"Poulsen, N. S., Dahlqvist, J. R., Hedermann, G., L\u00f8kken, N. & Vissing, J. Muscle contractility of leg muscles in patients with mitochondrial myopathies. Mitochondrion 46, 221\u2013227. https:\/\/doi.org\/10.1016\/j.mito.2018.07.001 (2019).","journal-title":"Mitochondrion"},{"issue":"1","key":"29759_CR11","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1038\/s41598-019-41240-y","volume":"9","author":"JR Dahlqvist","year":"2019","unstructured":"Dahlqvist, J. R. et al. Muscle contractility in spinobulbar muscular atrophy. Sci. Rep. 9(1), 4680. https:\/\/doi.org\/10.1038\/s41598-019-41240-y (2019).","journal-title":"Sci. Rep."},{"issue":"13","key":"29759_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1212\/WNL.0000000000000828","volume":"83","author":"JR Dahlqvist","year":"2014","unstructured":"Dahlqvist, J. R., Vissing, C. R., Thomsen, C. & Vissing, J. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy. Neurology 83(13), 1178\u20131183. https:\/\/doi.org\/10.1212\/WNL.0000000000000828 (2014).","journal-title":"Neurology"},{"issue":"3","key":"29759_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00415-016-8361-3","volume":"264","author":"G Andersen","year":"2017","unstructured":"Andersen, G. et al. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients. J. Neurol. 264(3), 438\u2013447. https:\/\/doi.org\/10.1007\/s00415-016-8361-3 (2017).","journal-title":"J. Neurol."},{"issue":"2","key":"29759_CR14","doi-asserted-by":"publisher","first-page":"e90377","DOI":"10.1371\/journal.pone.0090377","volume":"9","author":"TA Willis","year":"2014","unstructured":"Willis, T. A. et al. Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: A multinational cross-sectional study. PLoS ONE 9(2), e90377. https:\/\/doi.org\/10.1371\/journal.pone.0090377 (2014).","journal-title":"PLoS ONE"},{"issue":"3","key":"29759_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ana.24743","volume":"80","author":"N L\u00f8kken","year":"2016","unstructured":"L\u00f8kken, N., Hedermann, G., Thomsen, C. & Vissing, J. Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I. Ann. Neurol. 80(3), 466\u2013471. https:\/\/doi.org\/10.1002\/ana.24743 (2016).","journal-title":"Ann. Neurol."},{"issue":"1","key":"29759_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00421-010-1477-8","volume":"110","author":"S Cotofana","year":"2010","unstructured":"Cotofana, S. et al. Correlation between single-slice muscle anatomical cross-sectional area and muscle volume in thigh extensors, flexors and adductors of perimenopausal women. Eur. J. Appl. Physiol. 110(1), 91\u201397. https:\/\/doi.org\/10.1007\/s00421-010-1477-8 (2010).","journal-title":"Eur. J. Appl. Physiol."},{"issue":"3","key":"29759_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11357-015-9798-5","volume":"37","author":"JY Hogrel","year":"2015","unstructured":"Hogrel, J. Y. et al. NMR imaging estimates of muscle volume and intramuscular fat infiltration in the thigh: Variations with muscle, gender, and age. Age 37(3), 60. https:\/\/doi.org\/10.1007\/s11357-015-9798-5 (2015).","journal-title":"Age"},{"issue":"9\u201310","key":"29759_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.nmd.2005.07.002","volume":"15","author":"E Hammar\u00e9n","year":"2005","unstructured":"Hammar\u00e9n, E., Kjellby-Wendt, G. & Lindberg, C. Quantification of mobility impairment and self-assessment of stiffness in patients with myotonia congenita by the physiotherapist. Neuromuscul. Disord. NMD. 15(9\u201310), 610\u2013617. https:\/\/doi.org\/10.1016\/j.nmd.2005.07.002 (2005).","journal-title":"Neuromuscul. Disord. NMD."},{"issue":"13","key":"29759_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/01.wnl.0000257819.47628.41","volume":"68","author":"KA Vincent","year":"2007","unstructured":"Vincent, K. A., Carr, A. J., Walburn, J., Scott, D. L. & Rose, M. R. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 68(13), 1051\u20131057. https:\/\/doi.org\/10.1212\/01.wnl.0000257819.47628.41 (2007).","journal-title":"Neurology"},{"issue":"Pt 7","key":"29759_CR20","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/brain\/awt133","volume":"136","author":"JR Trivedi","year":"2013","unstructured":"Trivedi, J. R. et al. Non-dystrophic myotonia: Prospective study of objective and patient reported outcomes. Brain J. Neurol. 136(Pt 7), 2189\u20132200. https:\/\/doi.org\/10.1093\/brain\/awt133 (2013).","journal-title":"Brain J. Neurol."},{"issue":"1","key":"29759_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0022-510X(96)00037-8","volume":"143","author":"CD Reimers","year":"1996","unstructured":"Reimers, C. D., Schlotter, B., Eicke, B. M. & Witt, T. N. Calf enlargement in neuromuscular diseases: A quantitative ultrasound study in 350 patients and review of the literature. J. Neurol. Sci. 143(1), 46\u201356. https:\/\/doi.org\/10.1016\/S0022-510X(96)00037-8 (1996).","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"29759_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.nurt.2007.01.012","volume":"4","author":"CR Heatwole","year":"2007","unstructured":"Heatwole, C. R. & Moxley, R. T. The nondystrophic myotonias. Neurotherapeutics 4(2), 238\u2013251. https:\/\/doi.org\/10.1016\/j.nurt.2007.01.012 (2007).","journal-title":"Neurotherapeutics"},{"issue":"9","key":"29759_CR23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1212\/01.wnl.0000143383.91137.00","volume":"63","author":"TM Miller","year":"2004","unstructured":"Miller, T. M. et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 63(9), 1647\u20131655. https:\/\/doi.org\/10.1212\/01.wnl.0000143383.91137.00 (2004).","journal-title":"Neurology"},{"issue":"1","key":"29759_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-021-01212-8","volume":"9","author":"TO Krag","year":"2021","unstructured":"Krag, T. O., Holm-Yildiz, S., Witting, N. & Vissing, J. Autophagy is affected in patients with hypokalemic periodic paralysis: An involvement in vacuolar myopathy?. Acta Neuropathol. Commun. 9(1), 109. https:\/\/doi.org\/10.1186\/s40478-021-01212-8 (2021).","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"29759_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.nmd.2009.06.369","volume":"19","author":"J Trip","year":"2009","unstructured":"Trip, J. et al. Muscle ultrasound measurements and functional muscle parameters in non-dystrophic myotonias suggest structural muscle changes. Neuromuscul. Disord. NMD. 19(7), 462\u2013467. https:\/\/doi.org\/10.1016\/j.nmd.2009.06.369 (2009).","journal-title":"Neuromuscul. Disord. NMD."},{"issue":"8","key":"29759_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nmd.2013.05.001","volume":"23","author":"JM Morrow","year":"2013","unstructured":"Morrow, J. M. et al. Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul. Disord. NMD. 23(8), 637\u2013646. https:\/\/doi.org\/10.1016\/j.nmd.2013.05.001 (2013).","journal-title":"Neuromuscul. Disord. NMD."},{"issue":"4","key":"29759_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3988\/jcn.2015.11.4.331","volume":"11","author":"YH Lee","year":"2015","unstructured":"Lee, Y. H. et al. Whole-body muscle MRI in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: Evidence for chronic progressive myopathy with selective muscle involvement. J. Clin. Neurol. 11(4), 331\u2013338. https:\/\/doi.org\/10.3988\/jcn.2015.11.4.331 (2015).","journal-title":"J. Clin. Neurol."},{"issue":"4","key":"29759_CR28","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1212\/WNL.0000000000009828","volume":"95","author":"S Holm-Yildiz","year":"2020","unstructured":"Holm-Yildiz, S. et al. Permanent muscle weakness in hypokalemic periodic paralysis. Neurology 95(4), e342\u2013e352. https:\/\/doi.org\/10.1212\/WNL.0000000000009828 (2020).","journal-title":"Neurology"},{"issue":"5","key":"29759_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ncpneuro0178","volume":"2","author":"MG Hanna","year":"2006","unstructured":"Hanna, M. G. Genetic neurological channelopathies. Nat. Clin. Pract. Neurol. 2(5), 252\u2013263. https:\/\/doi.org\/10.1038\/ncpneuro0178 (2006).","journal-title":"Nat. Clin. Pract. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29759-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29759-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29759-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T14:19:36Z","timestamp":1676297976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29759-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29759"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29759-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2538"}}